Certara Q1 2025 revenue up 10% to $106M; net income positive vs year-ago loss

Certara, Inc.

2025-Q1 EPS reported $0.03 revenue$106,004,000

Revenue $106.0M (+10% YoY); software rev $46.4M (+18%), services $59.6M (+4%).
Net income $4.7M vs net loss of $4.7M in Q1 2024; adjusted EBITDA $34.8M (+20%).
Reiterated full-year 2025 financial guidance.
CEO cites FDA roadmap for reducing animal testing as opportunity for biosimulation.
CFO notes strong commercial execution despite biopharma headwinds.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.